RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer
Oghenekevwe M. Gbenedio(University of California, San Francisco), Philippe Depeille(University of California, San Francisco)
Cited by 23
Related Papers
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer
|Nature Communications|2024|95
A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2021|18